FEDERATED HERMES, INC. - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 89 filers reported holding RECRO PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2020$453,000
+35.6%
158,800
-0.1%
0.00%0.0%
Q3 2020$334,000
-73.6%
158,989
-42.9%
0.00%
-66.7%
Q2 2020$1,267,000
-62.7%
278,404
-33.1%
0.00%
-70.0%
Q1 2020$3,401,000
-56.3%
416,261
-2.0%
0.01%
-41.2%
Q4 2019$7,788,000
+1204.5%
424,859
+688.1%
0.02%
+1600.0%
Q3 2019$597,000
+4875.0%
53,908
+4484.0%
0.00%
Q2 2019$12,000
+140.0%
1,176
+139.0%
0.00%
Q1 2018$5,000
+400.0%
492
+351.4%
0.00%
Q3 2015$1,000
-90.0%
109
-86.5%
0.00%
Q2 2015$10,0008080.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders